Reviva Pharmaceuticals Holdings, Inc. (RVPH)
| Market Cap | 47.53M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 12.87M |
| EPS (ttm) | -0.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 518 |
| Open | 3.50 |
| Previous Close | 3.48 |
| Day's Range | 3.50 - 3.50 |
| 52-Week Range | 3.29 - 15.10 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Nov 15, 2021 |
About RVPH
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 that has completed Phase II clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials for treating bipolar disorder, major depressive disorder, behavioral and ps...
Financial Performance
Financial StatementsNews
Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
CUPERTINO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that ...
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business Highlights
-Closed Underwritten Public Offering of Common Stock and Warrants Resulting in Gross Proceeds of $34.5 Million
Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) is trading higher with around 60k in session volume. Maxim initiated coverage of Reviva with a Buy rating and $10 price target, equivalent to an upside...
Reviva Added to Russell Microcap® Index
CUPERTINO, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or the “Company”), a clinical-stage pharmaceutical compan...
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that se...
RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday
Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug. The post RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% ...
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today
Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and CRISPR Therapeutics AG (NASDAQCR...
Here's why Reviva Pharmaceuticals soared more than 100% on Monday
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) more than doubled in value Monday after the clinical-stage biopharmaceutical company reported encouraging phase 2 clinical trial results fo...
Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study Results
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) has announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine ...
Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute Schizophrenia
CUPERTINO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or the “Company”), a clinical-stage pharmaceutical compa...
Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update
-Closed Merger with Tenzing Acquisition Corp and publicly listed on NASDAQ Capital Market-
Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Ph...
Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW
Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc.
NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Tenzing Acquisition Corp.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Tenzi...
New York, New York--(Newsfile Corp. - July 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who own Tenzing Acquisition Corp.